US Stock MarketDetailed Quotes
EIGRQ Eiger BioPharmaceuticals
- 8.500
- 0.0000.00%
15min DelayClose Sep 27 16:00 ET
12.59MMarket Cap-724P/E (TTM)
0.000High0.000Low0Volume0.000Open8.500Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)1.48MShares16.00052wk High-17.93P/B7.24MFloat Cap1.10052wk Low--Dividend TTM852.06KShs Float12712.500Historical High--Div YieldTTM0.00%Amplitude1.100Historical Low--Avg Price1Lot Size
Eiger BioPharmaceuticals Key Stats
EPS
According to the latest financial report of Eiger BioPharmaceuticals, the latest earnings per share (TTM) for the company is -4.75. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Eiger BioPharmaceuticals's free cash flow? The latest report shows it as -13.96M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Eiger BioPharmaceuticals shows that the company's current ratio is 1.01, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Eiger BioPharmaceuticals, the quick ratio is 0.84, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Eiger BioPharmaceuticals? The latest ROE figure is -263.38%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Eiger BioPharmaceuticals, the total asset return on investment (ROA) is -13.18%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Eiger BioPharmaceuticals's latest financial report to see how their gross margin is doing - currently at 113.68%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Eiger BioPharmaceuticals, the net profit margin is 1.61K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data